November 30, 2023 Non Regulatory CORRECTION: AcuCort publishes the Interim Report for the first quarter 2023 (in Swedish)
November 30, 2023 Regulatory AcuCort publishes the Interim Report for the third quarter 2023 (in Swedish)
October 24, 2023 Non Regulatory AcuCort beviljas förlängd SME-status av den europeiska läkemedelsmyndigheten (EMA)
October 23, 2023 Non Regulatory AcuCort presenterar resultat från enkätstudie på den vetenskapliga konferensen ISPOR Europe
October 17, 2023 Regulatory AcuCort senarelägger publicering av delårsrapport för tredje kvartalet 2023
September 1, 2023 Non Regulatory (Omsänd) AcuCort skriver partneravtal för de fyra stora nordiska länderna med Unimedic Pharma
September 1, 2023 Non Regulatory (Retransmission) AcuCort signs partnership agreement for the four major Nordic countries with Unimedic Pharma
August 31, 2023 Regulatory AcuCort beslutar om en företrädesemission om cirka 30 MSEK samt upptar brygglån
August 31, 2023 Regulatory AcuCort skriver partneravtal för de fyra stora nordiska länderna med Unimedic Pharma
August 31, 2023 Regulatory AcuCort signs partnership agreement for the four major Nordic countries with Unimedic Pharma
May 15, 2023 Non Regulatory AcuCort is granted trademark protection for Zeqmelit® in the United Kingdom
April 28, 2023 Regulatory AcuCort publishes the Interim Report for the first quarter 2023 (in Swedish)
February 20, 2023 Regulatory FDA begär kompletterande uppgifter inför AcuCorts registreringsansökan i USA
February 20, 2023 Regulatory The FDA is requesting additional information prior to AcuCort's registration application in the United States
January 24, 2023 Non Regulatory AcuCort har lämnat in pris- och subventionsansökan till TLV avseende Zeqmelit®
January 24, 2023 Non Regulatory AcuCort has submitted the price and subsidy application to TLV regarding Zeqmelit®
January 24, 2023 Regulatory AcuCort får marknadsgodkännande av den finska läkemedelsmyndigheten för läkemedlet Zeqmelit®
January 24, 2023 Regulatory AcuCort receives market approval from the Finnish Medicines Agency for the drug Zeqmelit®